Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Genetic Variants in MATE1 and OCT3 Transporters on the Pharmacodynamics of Metformin in African Americans With Type II Diabetes Mellitus.

NCT01681693 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01681693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01681693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Genetic Variants in MATE1 and OCT3 Transporters on the Pharmacodynamics of Metformin in African Americans With Type II Diabetes Mellitus.
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2010
Completion date
July 31, 2013
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, type 2 diabetes mellitus